Research suggesting that COVID-19 is a vascular disease

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

Distinctive Features

COVID-19 is a vascular disease not a respiratory one, says study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular ...

COVID-19 – A vascular disease

Approximately 18 months ago, the first US case of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection was reported in Seattle, WA (1). Since 